Generic meds are back in the news.

Three weeks ago I wrote about a study that showed that eye doctors prescribe more brand name medications than any other speciality. The study suggested that health care spending could decrease if more generic medications were written. This week, the New York Times wrote an article about patients being denied generic medications.
Here is the gist of the article.
Historically patients have been told to ask for generic medication in place of the name brand medication. However, recently some patients are finding their insurance company will not allow a generic option. The New York Times stated that almost 30% of Americans have high deductible insurance plans through their employers which means the patient ends up absorbing the increased cost. “They often have to pick up the full sticker price of medications until they have paid out thousands of dollars.”
Why wouldn’t insurance companies want patients to use generic medication?
The theory is that pharmaceutical companies are negotiating deals with insurers to give priority to their brand name drug.
More article details here.

Get in Touch


Please enter your comment!
Please enter your name here

Related Articles

Optometry Podcast: Transitions® The Pulse, Feel the Love for Eyecare

Transitions® The Pulse will bring together eyecare industry professionals from over 42 countries with the first of its’ kind global virtual industry event on February 9th, 2021. “We’re gathering together to build that collective strength to help our businesses thrive and prosper in 2021,” King shares about the inspiration behind the event.

Latest Posts